Loomis, Sayles & Company
RXO icon

Loomis, Sayles & Company’s RXO RXO Stock Holding History

Loomis, Sayles & Company’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,307,867
Closed -$20.6M – 757
2025
Q2 		$20.6M Sell
1,307,867
-31,188
-2% -$473K 0.03% 240
2025
Q1 		$25.6M Sell
1,339,055
-28,453
-2% -$623K 0.04% 200
2024
Q4 		$32.6M Buy
1,367,508
+368,799
+37% +$10.3M 0.04% 180
2024
Q3 		$28M Buy
+998,709
New +$28.2M 0.04% 210
2023
Q4 		– Sell
-657
Closed -$13K – 1036
2023
Q3 		$13K Buy
657
+402
+158% +$7.92K ﹤0.01% 735
2023
Q2 		$6K Buy
+255
New +$5.14K ﹤0.01% 806

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Loomis, Sayles & Company's RXO Position: Q3 2025 in Review

Loomis, Sayles & Company sold out of RXO (RXO) in Q3 2025, closing a stake of 1,307,867 shares — an estimated $20.6M sold.

Loomis, Sayles & Company first reported a position in RXO in Q2 2023 and held it in 6 quarters. The position peaked at $32.6M in Q4 2024. 266 funds tracked by Wall St. Rank hold RXO as of Q3 2025.

  • Loomis, Sayles & Company reported no remaining RXO position as of Q3 2025 after selling out during the quarter.
  • Loomis, Sayles & Company sold 1,307,867 RXO shares in Q3 2025, an estimated $20.6M.
  • Loomis, Sayles & Company first reported a position in RXO in Q2 2023 and held it in 6 quarters.
  • Loomis, Sayles & Company's RXO position peaked at $32.6M in Q4 2024.
  • 266 funds tracked by Wall St. Rank held RXO as of Q3 2025.

Based on Loomis, Sayles & Company's 13F filing for Q3 2025, filed 13 Nov 2025.